338 related articles for article (PubMed ID: 26053398)
21. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology.
Zhang Q; Wang J; Dong R; Yang S; Zheng S
Mol Biol Rep; 2011 Jan; 38(1):631-8. PubMed ID: 20369385
[TBL] [Abstract][Full Text] [Related]
23. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
24. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
25. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
26. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
27. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.
Cazares LH; Diaz JI; Drake RR; Semmes OJ
Methods Mol Biol; 2008; 428():125-40. PubMed ID: 18287771
[TBL] [Abstract][Full Text] [Related]
28. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
29. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
30. Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
Jiao C; Jiao X; Zhu A; Ge J; Xu X
J Pediatr Surg; 2017 Apr; 52(4):618-624. PubMed ID: 28277300
[TBL] [Abstract][Full Text] [Related]
31. Time-of-flight mass spectrometry in screening serum-specific protein in patients with scrotal Paget's disease.
Zhao Z; Yang L; Zhang W; Wang H
Asia Pac J Public Health; 2013 Jul; 25(4 Suppl):30S-5S. PubMed ID: 23966602
[TBL] [Abstract][Full Text] [Related]
32. Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry.
Kim NA; Jin JH; Kim KH; Lim DG; Cheong H; Kim YH; Ju W; Kim SC; Jeong SH
Arch Pharm Res; 2016 May; 39(5):668-76. PubMed ID: 27002828
[TBL] [Abstract][Full Text] [Related]
33. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
[TBL] [Abstract][Full Text] [Related]
34. MALDI-TOF MS-based total serum protein fingerprinting for liver cancer diagnosis.
Park HG; Jang KS; Park HM; Song WS; Jeong YY; Ahn DH; Kim SM; Yang YH; Kim YG
Analyst; 2019 Mar; 144(7):2231-2238. PubMed ID: 30849133
[TBL] [Abstract][Full Text] [Related]
35. Detection and identification of potential biomarkers of breast cancer.
Fan Y; Wang J; Yang Y; Liu Q; Fan Y; Yu J; Zheng S; Li M; Wang J
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1243-54. PubMed ID: 20237941
[TBL] [Abstract][Full Text] [Related]
36. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
[TBL] [Abstract][Full Text] [Related]
37. Serum biomarker screening for the diagnosis of early gastric cancer using SELDI-TOF-MS.
Li P; Zhang D; Guo C
Mol Med Rep; 2012 Jun; 5(6):1531-5. PubMed ID: 22427025
[TBL] [Abstract][Full Text] [Related]
38. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
39. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
[TBL] [Abstract][Full Text] [Related]
40. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.
Schwegler EE; Cazares L; Steel LF; Adam BL; Johnson DA; Semmes OJ; Block TM; Marrero JA; Drake RR
Hepatology; 2005 Mar; 41(3):634-42. PubMed ID: 15726646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
